4 completed, 1 terminated. 5 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 4, Terminated 1 |
Follow Drug Interactions: new trials by email Literature Review of Drug Interactions trials Research Report on Drug Interactions
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate the Effect of Linaprazan Glurate on the Pharmacokinetics of Amoxicillin Drug Drug Interaction - Drug Interaction, GERD (Gastroesophageal Reflux Disease) | Phase 1 | Completed | Cinclus Pharma Holding AB | 12 | 2025-11-11 | 2026-02-27 |
| A Trial to Evaluate the Impact of C21 on the Exposure of 4 Substrates in Healthy Volunteers Drug Drug Interaction - Drug Interaction | Phase 1 | Completed | Vicore Pharma AB | 19 | 2023-03-29 | 2025-01-03 |
| Effect of Clarithromycin on PK of Linaprazan, Linaprazan on PK of Clarithromycin and Linaprazan on PK of Midazolam Linaprazan glurate, Drug drug interaction (DDI) - Clarithromycin (Part I), Drug drug interaction (DDI) - Midazolam (Part 2) - Safety Issues, Pharmacokinetics | Phase 1 | Completed | Cinclus Pharma Holding AB | 35 | 2022-11-27 | 2025-01-03 |
| GSK2647544 RD, DDI in Healthy Young and Elderly Volunteers GSK2647544, drug-drug interaction - Alzheimer's Disease | Phase 1 | Terminated | GlaxoSmithKline | 12 | 2013-11-22 | 2017-06-08 |
| Study Evaluating the Pharmacokinetics of the Potential Drug Interaction Between CYP2C9 Inhibitor and Substrate pharmacokinetic (how the body absorbs and eliminates) interaction - Healthy Subjects | Phase 1 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-07-01 | 2009-08-07 |
Alzheimer Disease (1) · Gastroesophageal Reflux (1)
Cinclus Pharma Holding AB (2) · GlaxoSmithKline (1) · Vicore Pharma AB (1) · Wyeth is now a wholly owned subsidiary of Pfizer (1)
Sweden (3) · United Kingdom (1)
Karin Palm (1)